Abstract
A high-performance thin-layer chromatographic method was developed and validated for simultaneous determination of Domperidone maleate (DOM) and Naproxen Sodium (NAP) in combined dosage formulation. The chromatography was performed on pre-coated silica gel 60 F 254 plates using Toluene: Dichloromethane: Ethyl acetate: GAA (5: 3: 2: 0.1 v/v/v/v) as mobile phase. Densitometric evaluation of the chromatograph was performed at 272 nm. The two drugs were satisfactorily resolved with Rf values 0.12 ± 0.02 and 0.70 ± 0.03 for DOM and NAP, respectively. The accuracy and reliability of the method was assessed by studying linearity for DOM (10–60 ng/band) and for NAP (250–1500 ng/band), presicion and accuracy and specificity, in accordance with ICH guidelines. The method determined the two drugs simultaneously from dosage forms without any interference of the tablet excipients. DOM and NAP were also subjected to acid, base, oxidation, heat and photodegradation studies. The degradation products obtained were well resolved from the pure drugs when subjected to acid and alkali degradation and oxidative stress. The developed method could effectively separate the drugs from its degradation products and hence can be used as a stability-indicating assay.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
